Form 4 for PFE Pfizer
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001225208-24-003055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | PFE | SUSMAN SALLY | EVP | M - OptEx | $27.34 | +63.8K | 218.1K | +41% | +$1.75M |
| DM | 2024-02-27 | 2024-02-23 | PFE | SUSMAN SALLY | EVP | F - Tax | $27.40 | -56.5K | 213.2K | -21% | -$1.55M |
| D | 2024-02-27 | 2024-02-23 | PFE | SUSMAN SALLY | EVP | M - OptEx | $0.00 | -63.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | M | A | 63,837 | $27.34 | 218,148 | D | — | — | (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2024-02-23 | F | D | 51,589 | $27.37 | 161,611 | D | — | — | (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
| 3 | Common | Common Stock | 2024-02-23 | F | D | 4,948 | $27.76 | 213,200 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| 4 | Derivative | Stock Appreciation Rights | 2024-02-23 | M | D | 63,837 | $0.00 | 0 | D | $27.34 · 2024-02-23 to 2024-02-23 | 63,837 Common Stock |